Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Diagnosing Skin Disease in Patients with Dark Skin

Thomas R. Collins  |  November 23, 2024

WASHINGTON, D.C.—Rheumatic skin diseases in patients of color often manifest in ways that defy the classic signs and can require a deeper look to make sure patients are diagnosed promptly, said Ginette Okoye, MD, professor and chair of dermatology at Howard University College of Medicine, Washington, D.C., in a session at ACR Convergence 2024.

And in another presentation, Laura Hummers, MD, ScM, co-director of the scleroderma center at Johns Hopkins University, Baltimore, described the many conditions that can mimic scleroderma. The similarities can cause confusion for clinicians, but that can be overcome if you are familiar with important subtle differences.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Melanin & More

Dr. Okoye

Dr. Okoye

Because skin diseases are so often diagnosed when erythema appears, darker skin can make identifying a problem more difficult, said Dr. Okoye.

“Melanin can mask erythema, it can mask redness, and we’re taught to look for redness when we’re trying to diagnose skin conditions,” she said. “And so if [the patient’s] melanin is masking that, it can lead to delays to diagnosis.” In people with darker skin, erythema could be red or purple, but it could also be dark brown, or bluish-black, she said.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

She discussed a patient of color with psoriasis, who, like many other patients, had some erythema but the redness was not the most prominent feature, “so really we’re relying on some of the other patterns that we see in skin disease” for diagnosis. These include the location of plaques and whether there is scaling, she said.

Dr. Okoye said clinicians should be comfortable ordering a biopsy when they are unsure what they are seeing on their physical exams. Since coming to Howard University, she said, “I have biopsied more psoriasis that I had in my career up until that point because I’d been fooled so many times.”

She discussed a patient with psoriasis on her scalp who had been diagnosed with seborrheic dermatitis for many years, with the only give-away being the pits in her nails. In these kinds of cases, with psoriasis involving the scalp in patients of African descent and with curly hair, she prescribes biologics very early on because the challenge of maintaining this hair type with psoriasis leads to quality-of-life struggles.

In a patient she discussed involving juvenile dermatomyositis, which typically involves a purplish heliotrope rash as a telltale sign, there was “no purple to be found.” Instead, there was only subtle hyperpigmentation and hypopigmentation.

Page: 1 2 3 | Single Page
Share: 

Filed under:ACR ConvergenceConditionsMeeting ReportsPsoriatic ArthritisSystemic Sclerosis Tagged with:ACR Convergence 2024

Related Articles

    A Case of Eosinophilic Fasciitis Presenting with Pansclerotic Morphea

    May 17, 2019

    Eosinophilic fasciitis generally presents with the acute onset of edema followed by progressive skin induration in the setting of hypergammaglobulinemia, an elevated erythrocyte sedimentation rate (ESR) and peripheral eosinophilia in 63–93% of patients.1,2 Skin involvement is typically limited to 20.1% of total body surface area and most commonly involves the extremities symmetrically.1,3 The condition was…

    Kamolrat/SHUTTERSTOCK.COM

    Eosinophilia: A Diagnostic Evaluation Guide for Rheumatologists

    June 15, 2015

    Clinical Vignette A 45-year-old woman with long-standing asthma and chronic sinusitis has new-onset peripheral neuropathy, arthralgias, fatigue, progressive dyspnea and a nonproductive cough. She has never smoked and has no environmental exposures. Her medications include an albuterol metered-dose inhaler (which she uses daily); an inhaled corticosteroid, montelukast; and ibuprofen (which she takes occasionally). She is…

    Fibrotic Diseases of the Retroperitoneum & Skin, & Rare Scleroderma Mimics

    January 19, 2018

    SAN DIEGO—Fibrosis affects all organ systems, but isn’t always systemic sclerosis. Experts on less common forms discussed patient presentations, diagnosis and treatment at the 2017 ACR/ARHP Annual Meeting in San Diego on Nov. 6. Retroperitoneal Fibrosis Formerly called Ormond’s disease, retroperitoneal fibrosis (RPF) is usually an IgG4-related disease, but has some unique characteristics, said John…

    Lost and found

    The History of ACE Inhibitors in Scleroderma Renal Crisis

    February 16, 2021

    Scleroderma renal crisis is a true medical emergency in rheumatology, one that requires prompt diagnosis and treatment. Here, we review the historic introduction of the angiotensin-converting enzyme inhibitors in this context, and highlight management and key questions moving forward. Background Awareness of renal disease in scleroderma dates back many years. The revered physician William Osler…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences